Berita Terbaru - Roche Merencanakan Studi Tominersen Baru
Some encouraging news has just come in from Roche. Analysis of the results of Roche’s Phase III GENERATION HD1 trial, which was stopped in March 2021, has found that a subset of patients may benefit from Tominersen. The analysis showed Baca lebih lanjut...